CHM chimeric therapeutics limited

Ann: Chimeric opens CHM CDH17 Phase 1/2 trial, page-17

  1. 294 Posts.
    lightbulb Created with Sketch. 92
    thanks Pfeiffer. Halperin is on the Board of Scientific Advisors for the NET Research Foundation, which provided funding to UPenn to develop the CDH17 CART therapy

    https://netrf.org/2023/11/20/research-milestone-in-netrf-funded-science-car-t-therapy-clinical-trial-announced-for-nets/.

    it would be an amazing outcome for his patients if the CDH17 therapy works
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.4¢
Change
0.000(0.00%)
Mkt cap ! $8.060M
Open High Low Value Volume
0.4¢ 0.4¢ 0.4¢ $20.21K 5.053M

Buyers (Bids)

No. Vol. Price($)
2 2213046 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 13563373 20
View Market Depth
Last trade - 15.01pm 24/06/2025 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.